Results 181 to 190 of about 7,331 (198)

Ivabradine prolongs phase 3 of cardiac repolarization and blocks the hERG1 (KCNH2) current over a concentration-range overlapping with that required to block HCN4

Journal of Molecular and Cellular Cardiology, 2015
James P Lees-Miller, Jiqing Guo, Yibo Wang   +2 more
exaly  

Ivabradine

2010
openaire   +1 more source

Effects on Outcomes of Heart Rate Reduction by Ivabradine in Patients With Congestive Heart Failure: Is There an Influence of Beta-Blocker Dose?

Journal of the American College of Cardiology, 2012
Karl Swedberg
exaly  

Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study

Clinical Research in Cardiology, 2012
, Jeffrey Borer, Ian Ford
exaly  

Reversal of Tachycardiomyopathy Due to Left Atrial Tachycardia by Ivabradine

Journal of Cardiovascular Electrophysiology, 2011
Shomu Bohora, Yash Lokhandwala
exaly  

Efficacy and Safety of Ivabradine in Chronic Heart Failure Across the Age Spectrum: Insights from the SHIFT Study

European Journal of Heart Failure, 2013
Luigi Tavazzi, Karl Swedberg
exaly  

Clinical Efficacy of Ivabradine in Patients With Inappropriate Sinus Tachycardia

Journal of the American College of Cardiology, 2012
Riccardo Cappato, Cristian Ricci, Luigi De Ambroggi   +2 more
exaly  

Duration of Chronic Heart Failure Affects Outcomes with Preserved Effects of Heart Rate Reduction with Ivabradine: Findings from SHIFT

European Journal of Heart Failure, 2018
, , Ian Ford
exaly  

Hemodynamic effects of Ivabradine in addition to dobutamine in patients with severe systolic dysfunction

International Journal of Cardiology, 2014
Romain Gallet, Julien Ternacle, Soulef Guendouz   +2 more
exaly  

Clinical Results of If Current Inhibition by Ivabradine

Drugs, 2012
Jean-Claude Tardif, Tardif Jean-Claude
exaly